[{"address1": "680 East Colorado Boulevard", "address2": "Suite 180", "city": "Pasadena", "state": "CA", "zip": "91101", "country": "United States", "phone": "631 830 7092", "fax": "631 982 5050", "website": "https://lixte.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colorectal cancer. The company's LB-100 combined with doxorubicin in advanced soft tissue sarcoma is under Phase 1b portion; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. Bastiaan  van der Baan M.Sc.", "age": 53, "title": "Chief Scientific Officer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 172784, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter M. Stazzone", "age": 74, "title": "Chief Financial Officer", "yearBorn": 1951, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.15, "open": 3.15, "dayLow": 3.04, "dayHigh": 3.22, "regularMarketPreviousClose": 3.15, "regularMarketOpen": 3.15, "regularMarketDayLow": 3.04, "regularMarketDayHigh": 3.22, "payoutRatio": 0.0, "beta": 0.836, "volume": 19608, "regularMarketVolume": 19608, "averageVolume": 94220, "averageVolume10days": 75430, "averageDailyVolume10Day": 75430, "bid": 3.0, "ask": 3.13, "bidSize": 1, "askSize": 1, "marketCap": 26457354, "fiftyTwoWeekLow": 0.64, "fiftyTwoWeekHigh": 6.26, "allTimeHigh": 110.4, "allTimeLow": 0.64, "fiftyDayAverage": 3.6718, "twoHundredDayAverage": 3.4927, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 17006252, "profitMargins": 0.0, "floatShares": 5697013, "sharesOutstanding": 8703077, "sharesShort": 120679, "sharesShortPriorMonth": 126115, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.0139, "heldPercentInsiders": 0.00929, "heldPercentInstitutions": 0.15348, "shortRatio": 1.14, "shortPercentOfFloat": 0.0139, "impliedSharesOutstanding": 8703077, "bookValue": 0.414, "priceToBook": 7.342995, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -4133687, "trailingEps": -1.19, "lastSplitFactor": "1:10", "lastSplitDate": 1685923200, "52WeekChange": 1.1328671, "SandP52WeekChange": 0.11527538, "quoteType": "EQUITY", "currentPrice": 3.04, "recommendationKey": "none", "totalCash": 2887874, "totalCashPerShare": 0.506, "totalDebt": 0, "quickRatio": 5.538, "currentRatio": 10.421, "returnOnAssets": -0.68318003, "returnOnEquity": -1.30059, "freeCashflow": -3476484, "operatingCashflow": -2581395, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "LIXT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Lixte Biotechnology Holdings, I", "longName": "Lixte Biotechnology Holdings, Inc.", "marketState": "CLOSED", "postMarketChangePercent": 0.0, "postMarketPrice": 3.04, "postMarketChange": 0.0, "regularMarketChange": -0.11, "regularMarketDayRange": "3.04 - 3.22", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 94220, "fiftyTwoWeekLowChange": 2.4, "fiftyTwoWeekLowChangePercent": 3.7500002, "fiftyTwoWeekRange": "0.64 - 6.26", "fiftyTwoWeekHighChange": -3.2200003, "fiftyTwoWeekHighChangePercent": -0.514377, "fiftyTwoWeekChangePercent": 113.28671, "dividendDate": 1605830400, "corporateActions": [], "postMarketTime": 1771621804, "regularMarketTime": 1771621202, "exchange": "NCM", "messageBoardId": "finmb_29181356", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -3.49207, "regularMarketPrice": 3.04, "earningsTimestampStart": 1754510400, "earningsTimestampEnd": 1754942400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.19, "fiftyDayAverageChange": -0.63179994, "fiftyDayAverageChangePercent": -0.17206818, "twoHundredDayAverageChange": -0.45270014, "twoHundredDayAverageChangePercent": -0.12961324, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1193319000000, "displayName": "Lixte Biotechnology", "trailingPegRatio": null, "__fetch_time": "2026-02-21"}]